Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Novavax, Inc. (NVAX)
- Structure Therapeutics Inc. Sponsored ADR GPCR 18.19 −2.05%
- Novavax, Inc. NVAX 7.95 −1.36%
Structure Therapeutics Inc. Sponsored ADR and Novavax, Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Novavax, Inc. are of similar size ($1.3B and $1.3B). Structure Therapeutics Inc. Sponsored ADR has the higher net margin (0.00% vs −18.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Novavax, Inc. leads on 8 and Structure Therapeutics Inc. Sponsored ADR on 4.
Valuation
Profitability
| Metric | GPCR | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 78.01% | 70.18% |
| Operating margin | 0.00% | (21.23%) | 0.00% |
| Net margin | 0.00% | (18.64%) | 0.00% |
| Free cash flow margin | 0.00% | (59.25%) | 0.00% |
| Return on equity | (29.51%) | 41.08% | (50.72%) |
| Return on assets | (27.13%) | (7.42%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack